(MedPage Today) — Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in real-world settings versus what is reported in clinical trials, likely because patients discontinue treatment…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/115999
Author :
Publish date : 2025-06-10 17:48:00
Copyright for syndicated content belongs to the linked Source.
